Northrop Grumman Corporation
NOC
$550.00
+1.72%
Northrop Grumman Corporation is a premier global aerospace and defense technology company, providing advanced systems and products across aeronautics, defense, mission, and space segments. It is a leading prime contractor and systems integrator, distinguished by its role in critical national security programs such as the B-21 Raider stealth bomber, the F-35 fuselage, and advanced space systems. The current investor narrative is dominated by the powerful tailwind of proposed massive increases in U.S. defense spending, particularly for missile defense and next-generation platforms, juxtaposed against recent stock price volatility and concerns over execution on major programs.…
NOC
Northrop Grumman Corporation
$550.00
Related headlines
NOC 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Northrop Grumman Corporation's 12-month outlook, with a consensus price target around $715.00 and implied upside of +30.0% versus the current price.
Average Target
$715.00
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$440 - $715
Analyst target range
Analyst coverage for NOC appears limited in the provided data, with only 8 analysts cited for EPS estimates, and no explicit buy/hold/sell distribution or price targets are available in the dataset. The estimated EPS range for the forward period is $36.61 to $38.18, with an average of $37.30, indicating a relatively tight consensus on near-term earnings. The lack of explicit price target data suggests that while the company is a major institutional holding, detailed consensus metrics are not fully captured here; investors should consult additional sources for the full analyst sentiment picture, which historically for NOC has leaned bullish due to its entrenched market position and defense budget tailwinds.
Bulls vs Bears: NOC Investment Factors
The evidence is currently balanced but tilts bearish in the near term due to severe technical damage and momentum breakdown. The bull case is fundamentally sound, anchored in a powerful defense spending cycle and strong cash generation. However, the bear case is reinforced by a 20%+ monthly decline that suggests the market is pricing in heightened execution and competitive risks. The single most important tension is between the long-term, structural tailwind of elevated defense budgets and the near-term risk of operational stumbles or budget re-prioritization that could derail NOC's premium valuation. The resolution of this tension—specifically, clear evidence of flawless execution on key programs in upcoming quarters—will determine the stock's direction.
Bullish
- Strong Defense Spending Tailwind: The U.S. defense budget is proposed to surge to Cold War-era levels, with a potential $1.5 trillion for 2027. As a prime contractor on critical programs like the B-21 Raider and missile defense, NOC is positioned for significant, long-term revenue growth from this structural tailwind.
- Robust Profitability and Cash Flow: The company generates strong free cash flow of $3.31 billion TTM, funding dividends and share repurchases ($456M in Q4). Q4 net margin of 12.18% and operating income of $1.04 billion demonstrate solid execution on its large contract portfolio.
- Valuation Near Midpoint of Historical Range: The trailing P/E of 19.57x sits near the midpoint of its historical range (from ~10x to 38x), suggesting the recent 20%+ correction has removed excessive optimism. The forward P/E of 17.91x implies modest earnings growth expectations, offering a balanced entry point.
- Sequential Revenue and Margin Improvement: Q4 2025 revenue grew 9.6% YoY to $11.71B, continuing a sequential climb from $9.47B in Q1. Operating income improved from $573M in Q1 to $1.04B in Q4, indicating strengthening operational execution throughout the fiscal year.
Bearish
- Severe Technical Downtrend and Volatility: The stock is down 20.32% over the past month and 23.04% over three months, trading at 70% of its 52-week range. This sharp reversal from highs near $774 signals a severe loss of momentum and potential trend breakdown, with support at the 52-week low of $466.38.
- Execution Risk on Major Programs: Recent news highlights competitive threats in next-gen missile defense (e.g., Rocket Lab/RTX partnership) and potential program-specific risks. The stock's recent decline may reflect investor concerns over NOC's ability to execute flawlessly on massive, complex contracts like the B-21.
- Leveraged Balance Sheet: A debt-to-equity ratio of 1.18 indicates significant leverage. While manageable given strong cash flows, it increases financial risk if interest rates remain elevated or if program delays pressure cash generation.
- Vulnerability to Political and Budget Cycles: Despite proposed increases, defense budgets are subject to political negotiation and shifting priorities. The stock's high volatility (52-week range >$307) and recent underperformance vs. the market (RSI -25.9 over 1 month) reflect sensitivity to these macro and policy uncertainties.
NOC Technical Analysis
The stock is in a pronounced downtrend from its recent highs, having declined 20.32% over the past month and 23.04% over the past three months, which starkly contrasts with its positive 15.27% gain over the past year. Currently trading at $540.69, the price sits at approximately 70% of its 52-week range ($466.38 to $774.00), indicating a significant retreat from its highs and positioning it closer to the lower bound, which may attract value-oriented investors but also signals a loss of momentum. Recent momentum is decisively negative and diverging sharply from the longer-term uptrend; the 1-month decline of 20.32% and 3-month decline of 23.04% suggest a severe correction or trend reversal, potentially driven by profit-taking or concerns over execution following its earlier surge. The stock's beta of -0.113 is anomalous and suggests it has moved inversely to the market recently, but its high volatility is better illustrated by a 52-week range spanning over $307, indicating significant price swings. Key technical support is the 52-week low of $466.38, while resistance is the recent high of $774.00; a breakdown below support would signal a continuation of the bearish trend, while a recovery above the $600-$650 zone would be needed to suggest the correction has ended.
Beta
-0.11
-0.11x market volatility
Max Drawdown
-29.6%
Largest decline past year
52-Week Range
$468-$774
Price range past year
Annual Return
+16.2%
Cumulative gain past year
| Period | NOC Return | S&P 500 |
|---|---|---|
| 1m | -17.3% | +4.0% |
| 3m | -21.6% | +8.2% |
| 6m | -2.7% | +11.5% |
| 1y | +16.2% | +24.3% |
| ytd | -6.1% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NOC Fundamental Analysis
Revenue growth remains solid, with Q4 2025 revenue of $11.71 billion representing a 9.6% year-over-year increase, continuing a trend of sequential quarterly growth from $9.47 billion in Q1 to the Q4 peak. The Aeronautics Systems segment, at $3.92 billion, is the largest contributor, followed by Mission Systems at $3.45 billion, indicating balanced growth across its portfolio. Profitability is robust, with Q4 net income of $1.43 billion and a net margin of 12.18%, though gross margin of 19.6% reflects the cost-plus nature of many defense contracts. Margins have shown some quarterly variability, with operating income improving from $573 million in Q1 to $1.04 billion in Q4, suggesting operational execution is strengthening through the year. The balance sheet is leveraged but manageable, with a debt-to-equity ratio of 1.18 and a current ratio of 1.09, indicating adequate short-term liquidity. Cash flow generation is strong, with trailing twelve-month free cash flow of $3.31 billion, providing ample internal funding for dividends, share repurchases ($456 million in Q4), and capital expenditures, supporting a healthy financial position.
Quarterly Revenue
$11.7B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.19%
Latest Quarter
Free Cash Flow
$3.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NOC Overvalued?
Given its consistent profitability, the primary valuation metric is the P/E ratio. The trailing P/E is 19.57x, while the forward P/E is 17.91x, indicating the market expects modest earnings growth, with the forward multiple implying a slight discount to current earnings. Compared to sector averages, NOC's trailing P/E of 19.57x is likely at a premium to many industrials, but this is typical for high-quality, large-cap defense primes with visible long-term backlogs and is justified by its strategic role and growth outlook. Historically, the stock's own trailing P/E has fluctuated significantly, from lows near 10x in late 2022 to highs above 38x in early 2025; the current 19.57x sits near the midpoint of this range, suggesting the valuation is neither excessively optimistic nor overly pessimistic relative to its own history, potentially offering a balanced entry point after the recent correction.
PE
19.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -33x~38x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Northrop Grumman carries a leveraged balance sheet with a debt-to-equity ratio of 1.18, which, while supported by $3.31B in annual FCF, creates vulnerability to rising interest costs. Margins, while improving sequentially, exhibit quarterly variability (gross margin of 19.6% in Q4) inherent to cost-plus contracts, and profitability is dependent on efficient execution across a portfolio of massive, multi-year programs. Any significant cost overrun or delay on a flagship program like the B-21 could pressure cash flows and trigger a re-rating.
Market & Competitive Risks: The stock trades at a trailing P/E of 19.57x, a premium to many industrials, making it susceptible to valuation compression if growth expectations moderate. Recent news highlights emerging competitive threats in next-generation missile defense from non-traditional players like Rocket Lab. Furthermore, the stock's high volatility (beta of -0.113 recently, but a 52-week range of over $307) and sharp underperformance versus the S&P 500 (-25.9% RSI over 1 month) indicate it is highly sensitive to sector rotation and shifts in investor sentiment toward defense stocks.
Worst-Case Scenario: The most damaging scenario involves a major technical breakdown below the $466.38 support level, triggered by a significant cost overrun or delay on a key program concurrent with a political compromise that scales back proposed defense budget increases. This could lead to multiple compression toward the lower end of its historical P/E range (~10-12x) and a rapid decline toward the $466 low. From the current price of $540.69, this represents a realistic downside of approximately -14% to that technical level, with potential for further declines if sentiment sours severely.
